Clinical Trial Update: Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating gemtuzumab ozogamicin in young patients with newly diagnosed acute myeloid leukemia undergoing remission-induction and intensi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Gemtuzumab ozogamicin (gemtuzumab ozogamicin)

Snippet

Sponsor: Children's Oncology Group | Conditions: Leukemia | Phase 2 | Status: COMPLETED